Autopsy report · NCT05118360

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH

“This study has been cancelled due to business reasons”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Gannex Pharma Co., Ltd.

Sponsor type

Industry

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

ASC41 2 mg; ASC41 4 mg; Placebo

Participants

0

Trials that died the same way

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
  “The study was terminated due to strategic business reasons.” (82% match in meaning)
• Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
  “Study was cancelled by Sponsor.” (81% match in meaning)
• Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
  “The study was terminated due to a business decision.” (81% match in meaning)
• Study of Select Combinations in Adults With Myelofibrosis
  “This study was cancelled before enrolling any patients for business related reasons.” (80% match in meaning)
• An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
  “Study was prematurely terminated due to administrative and strategic reasons” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.